Rachel M. Levine
-
- RNA Interference and Gene Delivery 7
- Advanced biosensing and bioanalysis techniques 5
- CRISPR and Genetic Engineering 4
- Pluripotent Stem Cells Research 2
-
- Virus-based gene therapy research 3
- Hemoglobinopathies and Related Disorders 3
-
- Prenatal Screening and Diagnostics 2
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Efrosini KokkoliEric P. KrenningMaroof M. AdilKenneth H. CowanMerrill E. GoldsmithTimothy R. PearceArthur W. NienhuisEC Douglass
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (2 papers)Blood (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Rachel M. Levine
22 papers receiving 554 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Biomaterials 83
- Business and International Management 12
- Geriatrics and Gerontology 22
- Molecular Biology 322
- Genetics 45
Countries citing papers authored by Rachel M. Levine
This map shows the geographic impact of Rachel M. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M. Levine more than expected).
Fields of papers citing papers by Rachel M. Levine
This network shows the impact of papers produced by Rachel M. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M. Levine. The network helps show where Rachel M. Levine may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel M. Levine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in micebreakdown → | 2023 | 85 |
| 3 | 2022 | 8 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 46 | |
| 7 | 2019 | 10 | |
| 8 | 2019 | 1 | |
| 9 | 2019 | 19 | |
| 10 | 2017 | 62 | |
| 11 | 2017 | 28 | |
| 12 | 2014 | 8 | |
| 13 | 2013 | 38 | |
| 14 | 2012 | 16 | |
| 15 | 2011 | 42 | |
| 16 | 2010 | 29 | |
| 17 | 2006 | 4 | |
| 18 | 2006 | 4 | |
| 19 | 1986 | 23 | |
| 20 | 1982 | 65 |
About Rachel M. Levine
Rachel M. Levine is a scholar working on Business and International Management, Genetics and Genetics, having authored 22 papers that have together received 571 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), CRISPR and Genetic Engineering (4 papers), Virus-based gene therapy research (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Pluripotent Stem Cells Research (2 papers), Prenatal Screening and Diagnostics (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Biomaterials (83 citations), Business and International Management (12 citations) and Geriatrics and Gerontology (22 citations). Rachel M. Levine has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Efrosini Kokkoli, Eric P. Krenning, Maroof M. Adil, Kenneth H. Cowan, Merrill E. Goldsmith, Timothy R. Pearce, Arthur W. Nienhuis, EC Douglass, Neil J. Clendeninn and Susan C. Aitken. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.